Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes.
D000959:Antihypertensive Agents; D003863:Depression / Q000209:etiology*; D003866:Depressive Disorder; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011618:Psychotic Disorders; D011926:Rauwolfia; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects*
D000959:Antihypertensive Agents; D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine
DEPRESSION/etiology and pathogenesis; HYPERTENSION/therapy; PSYCHOSES, TOXIC/etiology and pathogenesis; RAUWOLFIA ALKALOIDS/injurious effects